This brand name is authorized in Nigeria.
The drug XPLENDED contains one active pharmaceutical ingredient (API):
1
|
UNII
83MVU38M7Q - ROSUVASTATIN CALCIUM
|
Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
B4-9122 | Tablet | Xplended Tablets 5 mg TAB 5 mg 3 X 10 | 50 RNW-PP-362721 Xplended Tablets 5mg ROSUVASTATIN 5mg 5.2 mg rosuvastatin (as rosuvastatin calcium),M.C. Cellulose PH -102 Tablettose 80 H.P.M.C Pharmacoat 606 (2910) Iron Oxide Yellow Crospovidone Colloidal Silicon Dioxide (Aerosil 200) Magnesium Stearate Sodium Dodecyl Sulphate Opadry White ii 85G68918 Purified Water B4-9122 Drugs Imported Products 310 Prescription Only Medicine (POM) 10/13/2023 FENSYL MHP CONSULTING LIMITED, NO. 49, KOFO ABAYOMI STREET, APAPA NULL NULL, LAGOS 8033221004 fensylmhpconsultingltd@gmail.com PharmEvo (PVT) Limited, Plot No. A-29, North Western Industrial Zone, Port Qasim, Karachi-75020, Pakistan. , Pakistan | 25/09/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
C10AA07 | Rosuvastatin | C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | B4-9121, B4-9122 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.